Schedule 13D ownership disclosure

AKOUSTIS TECHNOLOGIES INC

Common Stock · CUSIP: 00973N102

Event date: 2026-01-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MPM BIOVENTURES 2018, L.P.Reported CIK 0001729505

    Shares: 3,950,528.00 · Class: 7.4%

  • MPM BIOVENTURES 2018 (B), L.P.Reported CIK 0001729504

    Shares: 206,964.00 · Class: 0.4%

  • MPM BioVentures 2018 GP LLCReported CIK 0001818701

    Shares: 4,157,492.00 · Class: 7.8%

  • MPM ASSET MANAGEMENT INVESTORS BV2018 LLCReported CIK 0001734817

    Shares: 77,911.00 · Class: 0.1%

  • MPM BioVentures 2018 LLCReported CIK 0001818702

    Shares: 4,235,403.00 · Class: 7.9%

  • MPM ONCOLOGY INNOVATIONS FUND LPReported CIK 0001719960

    Shares: 847,080.00 · Class: 1.6%

  • MPM Oncology Innovations Fund GP LLCReported CIK 0001857903

    Shares: 847,080.00 · Class: 1.6%

  • Oncology Impact Private Investment Fund 2, L.P.Reported CIK 0002104306

    Shares: 4,835,872.00 · Class: 9.1%

  • MPM Oncology Investments 2 LLC

    Shares: 4,835,872.00 · Class: 9.1%

  • MPM ASSET MANAGEMENT LLCReported CIK 0001263048

    Shares: 341,709.00 · Class: 0.6%

  • ANSBERT GADICKEReported CIK 0001134655

    Shares: 10,260,064.00 · Class: 19.3%

  • LUKE EVNINReported CIK 0001134657

    Shares: 5,082,483.00 · Class: 9.5%

  • Todd FoleyReported CIK 0001473930

    Shares: 4,237,506.00 · Class: 8.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-26-000070
Form type
SCHEDULE 13D
Filer
Aktis Oncology, Inc.
CIK
CIK 2035832
Filed
Jan 20, 2026
Reporting period
Jan 12, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub